市場調查報告書
商品編碼
1402736
亞太地區母乳強化劑市場預測至 2030 年 - 區域分析 - 按形式(粉末和液體)和配銷通路(線上和線下)Asia Pacific Human Milk Fortifier Market Forecast to 2030 - Regional Analysis - by Form (Powder and Liquid) and Distribution Channel (Online and Offline) |
亞太母乳強化劑市場預計將從2023年的7,953萬美元成長到2030年的1.5,905億美元;預計2023年至2030年CAGR為10.4%。
發展中國家意識的提高推動亞太母乳強化劑市場
近年來,嬰兒營養品已成為亞太地區最賺錢的市場之一。人口成長、經濟穩定發展和人均收入增加是推動市場的主要因素。中國、印度和韓國等國家的人們高度關注兒童的健康和福祉,並廣泛採用母乳強化劑來支持他們的生長和發育。母乳強化劑的概念對於新興經濟體的許多人來說是新的,人們意識的不斷增強預計將為市場成長創造有利可圖的機會。由於人們對母乳強化劑的益處(例如促進生長和骨骼發育)的認知不斷提高,母乳強化劑市場正在獲得巨大的吸引力。發展中國家的健康協會正在採取措施促進早產兒的整體生長並改善營養。例如,2021 年 7 月,NeoLacta Lifesciences 宣布根據世界衛生組織 (WHO) 的指導方針在印度開發 100% 母乳強化劑。該產品旨在提高新生兒的營養護理品質。
因此,發展中國家對母乳強化劑的認知不斷提高,預計將在預測期內為市場提供利潤豐厚的成長機會。
亞太地區母乳強化劑市場概況
家長和醫療保健專業人員對母乳強化劑營養益處的認知不斷提高,推動了對該產品的需求。此外,新生兒護理的進步提高了早產兒的存活率,導致對母乳強化劑的需求增加。這些強化劑為早產兒提供必需的營養素並促進更好的健康結果。隨著亞太地區可支配所得水準的上升,越來越多的父母能夠負擔得起優質保健產品,包括母乳強化劑。這促進了市場的成長,因為父母願意投資能夠改善孩子健康和福祉的產品。此外,亞太地區醫療基礎設施的擴張,包括新生兒加護病房(NICU),為母乳強化劑市場的成長創造了有利的環境。醫院和醫療機構擁有更好的裝備,可以為早產兒提供專門護理,從而促進母乳強化劑需求的增加。
亞太地區母乳強化劑市場收入及 2030 年預測(百萬美元)
亞太地區母乳強化劑市場區隔
亞太地區母乳強化劑市場依據形式、配銷通路和國家進行細分。根據形式,亞太母乳強化劑市場分為粉末和液體。到 2023 年,粉末細分市場將佔據更大的市場佔有率。
根據配銷通路,亞太母乳強化劑市場分為線上和線下。 2023年,線下細分市場佔有更大的市場佔有率。
依國家/地區分類,亞太地區母乳強化劑市場分為澳洲、中國、印度、日本、韓國和亞太地區其他地區。 2023年,中國在亞太母乳強化劑市場佔據主導地位。
Abbott Laboratories、NeoLacta Lifesciences Pvt Ltd、Nestle SA、Prolacta Bioscience Inc、Lead Care International Ltd、Raptakos、Brett & Co Ltd、Danone SA 和 Reckitt Benckiser Group Plc 是亞太母乳強化劑市場上的一些領先公司。
The Asia Pacific human milk fortifier market is expected to grow from US$ 79.53 million in 2023 to US$ 159.05 million by 2030; it is estimated to grow at a CAGR of 10.4% from 2023 to 2030.
Rising Awareness in Developing Countries fueling the Asia Pacific Human Milk Fortifier Market
In recent years, infant nutrition has been one of the most lucrative markets in Asia Pacific. Rise in population, steady economic development, and increase in per capita income are among the major factors driving the market. People in countries such as China, India, and South Korea are highly concerned about their children's health and well-being and are widely adopting human milk fortifiers to support their growth and development. The concept of human milk fortifiers is new to many people in emerging economies, and the increasing awareness among people is expected to create lucrative opportunities for the market growth. The human milk fortifier market is gaining significant traction owing to increasing awareness regarding the benefits of human milk fortifiers, such as promoting growth and bone development. Health associations in the developing countries are taking initiatives to boost overall growth and improve nutrition in preterm babies. For instance, in July 2021, NeoLacta Lifesciences announced the development of a 100% human milk fortifier in India as per the guidelines of the World Health Organization (WHO). The product aims to improve the quality of nutritional care for newborns.
Thus, the rising awareness about human milk fortifiers in developing countries is expected to provide lucrative growth opportunities for the market during the forecast period.
Asia Pacific Human Milk Fortifier Market Overview
Increased awareness among parents and healthcare professionals about the nutritional benefits of human milk fortifiers is driving the demand for this product. Also, advances in neonatal care have improved the survival rates of premature infants, leading to a higher demand for human milk fortifiers. These fortifiers provide essential nutrients and promote better health outcomes for preterm babies. As disposable income levels rise in Asia Pacific, more parents can afford premium healthcare products, including human milk fortifiers. This has contributed to the market growth, as parents are willing to invest in products that can improve their child's health and well-being. Moreover, the expansion of healthcare infrastructure, including neonatal intensive care units (NICUs), across Asia Pacific has created a favorable environment for the human milk fortifier market growth. Hospitals and healthcare facilities are better equipped to provide specialized care for premature infants, contributing to the increased demand for human milk fortifiers.
Asia Pacific Human Milk Fortifier Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Human Milk Fortifier Market Segmentation
The Asia Pacific human milk fortifier market is segmented based on form, distribution channel, and country. Based on form, the Asia Pacific human milk fortifier market is bifurcated into powder and liquid. The powder segment held a larger market share in 2023.
Based on distribution channel, the Asia Pacific human milk fortifier market is bifurcated into online and offline. The offline segment held a larger market share in 2023.
Based on country, the Asia Pacific human milk fortifier market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific human milk fortifier market in 2023.
Abbott Laboratories, NeoLacta Lifesciences Pvt Ltd, Nestle SA, Prolacta Bioscience Inc, Lead Care International Ltd, Raptakos, Brett & Co Ltd, Danone SA, and Reckitt Benckiser Group Plc are some of the leading companies operating in the Asia Pacific human milk fortifier market.